Status:
UNKNOWN
L Test in Multiple Sclerosis
Lead Sponsor:
Firat University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Brief Summary
Multiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system, is a disease characterized by myelin, oligodendrocyte and axon damage \[1\]. Research continues on the autoimmune...
Detailed Description
General Information about the Research, Rationale and Objectives: Multiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system, is a disease characterized by myelin, oligoden...
Eligibility Criteria
Inclusion
- Inclusion criteria for volunteers; Individuals with relapsing-remitting type MS, who are between 18-65, EDSS scores between 1 ≤ and ≤ 5.5, individuals who score 24 and above in Mini Mental State Examination and who can walk a minimum of 20 m independently will be included.
Exclusion
- In addition, exclusion criteria for volunteers; Severe spasticity of the lower extremities (Ashworth score 3 or 4), having an acute MS attack or a history of an attack in the last 1 month, having an orthopedic or systemic problem that would prevent participation in the tests, having another neuromuscular disorder other than MS, visual involvement or diplopia, and is that he has a cardio-pulmonary problem that will prevent him from participating in the tests.
Key Trial Info
Start Date :
February 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 9 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05325359
Start Date
February 7 2022
End Date
May 9 2022
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fırat university
Elâzığ, Turkey (Türkiye), 23100